Provencio Pulla, M., Berry, L., Quintana, M., LeBlanc, T. W., Mascaux, C., Schabath, M., … Stenehjem, D. (2024). 1230P Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study. In Annals of Oncology (Vol. 35, pp. S789–S790). Elsevier BV. https://doi.org/10.1016/j.annonc.2024.08.1289

Provencio Pulla, M., L. Berry, M. Quintana, T. W. LeBlanc, C. Mascaux, M. Schabath, C. M. Bestvina, et al. “1230P Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study.” In Annals of Oncology, 35:S789–90. Elsevier BV, 2024. https://doi.org/10.1016/j.annonc.2024.08.1289.

Provencio Pulla M, Berry L, Quintana M, LeBlanc TW, Mascaux C, Schabath M, et al. 1230P Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study. In: Annals of Oncology. Elsevier BV; 2024. p. S789–90.

Provencio Pulla, M., et al. “1230P Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study.” Annals of Oncology, vol. 35, Elsevier BV, 2024, pp. S789–90. Crossref, doi:10.1016/j.annonc.2024.08.1289.

Provencio Pulla M, Berry L, Quintana M, LeBlanc TW, Mascaux C, Schabath M, Bestvina CM, Tratt M, Mansfield AS, Bates M, Gentzler RD, Girard N, Couraud S, Tan CJ, Wislez M, Wei B, Calvet C, Berry DA, Vo L, Stenehjem D. 1230P Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study. Annals of Oncology. Elsevier BV; 2024. p. S789–S790.